Feverfew
Natural health product licensed in Canada
- Licence holder
- Wholesome Plus Marketing Inc.
- NPN or DIN-HM
- 80002641
- Status
- Active licence
- Licence date
- 10 January 2007
- Revision date
- 14 July 2022
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Tanacetum parthenium | 200 mg | Not calculated |
Non-medicinal ingredients
Poly(éthylène glycol), Gélatine, cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | Not specified |
Uses authorised in Canada
Clinically shown to help reduce the severity and/or frequency of migraine headaches and associated nausea and vomiting when taken as a prophylactic.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy is know to occur; in which case, discontinue use. Sore mouth or mouth ulsers and/or gastrointestinal disconfort are know to occur; in wich case, discontinue use.
- Contre-indications
Do not use if you are pregnant. Do not use if you are allergic to plants of the Asteraceae/Compositae (daisy) family.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking blood thinners. Consult a health care practitioner if you are breastfeeding. Consult a health care practitioner if symptoms persist ot worsen.
Source
Official Health Canada record, licence 80002641
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging